Contents
TLDR
- Daniel Ives from Wedbush established a Wall Street-leading $350 price target for Apple, suggesting approximately 34% upside potential while maintaining an Outperform rating
- The tech giant’s refreshed Mac portfolio — featuring M5-equipped MacBook Air/Pro models and the budget-friendly $599 MacBook Neo — could trigger an AI-driven replacement cycle
- Apple exceeded Q1 projections with earnings per share of $2.84 (versus $2.67 consensus) and $143.76 billion in revenue, marking a 15.7% year-over-year increase
- Oppenheimer Asset Management expanded its AAPL holdings by 9% during Q3, joining major institutional players like Vanguard and State Street in increasing positions
- Analyst consensus stands at Moderate Buy for AAPL with a mean price target of $306.12; shares began Friday trading at $260.29
Apple (AAPL) stock is capturing renewed interest following Wedbush’s decision to establish a $350 price target — Wall Street’s most bullish forecast — as institutional money managers quietly expand their stakes and the company delivers impressive quarterly performance.
On March 6, Wedbush’s Daniel Ives announced the new Street-leading price objective while maintaining his Outperform rating. With shares trading near $260, this target suggests potential gains of approximately 34%. Ives highlighted Apple’s enhanced Mac product range, powered by its latest M5 processors, as a critical catalyst for what he anticipates will be an artificial intelligence-driven hardware replacement wave.
The refreshed product lineup features redesigned MacBook Air and MacBook Pro variants equipped with M5 chips that deliver enhanced AI capabilities, improved memory performance, and extended battery endurance. Additionally, Apple unveiled the MacBook Neo, a 13-inch notebook priced from $599, specifically targeting budget-conscious consumers and educational institutions.
Ives emphasized that approximately half of recent Mac purchasers represent first-time platform adopters — a metric he interprets as confirmation that Apple is successfully broadening its customer base rather than merely serving existing users.
Gene Munster alongside other market watchers have suggested the MacBook Neo and iPhone 17e could generate supplementary revenue streams and enable Apple to capture market share in budget-friendly and educational categories. Wedbush characterized the diversified product spectrum, spanning premium AI-enabled laptops to affordable entry-level options, as a strategy to generate “incremental upside” for Mac division sales.
Strong Quarterly Performance Bolsters Optimism
Apple’s latest quarterly financial disclosure, released January 29, provided additional ammunition for optimistic investors. The company delivered earnings per share of $2.84, surpassing the analyst consensus of $2.67 by $0.17. Revenue reached $143.76 billion, exceeding projections of $138.25 billion and representing a 15.7% year-over-year climb.
Return on equity measured 159.94%, accompanied by a net profit margin of 27.04%. Market analysts currently project full-year earnings per share of $7.28 for the ongoing fiscal period.
Apple distributed a quarterly dividend of $0.26 per share on February 12, translating to an annualized dividend of $1.04 and a yield of 0.4%.
Oppenheimer Asset Management expanded its AAPL position by 9% during Q3, elevating its holdings to 362,318 shares worth approximately $92.26 million. AAPL now constitutes 1.0% of Oppenheimer’s aggregate portfolio and ranks as its 12th largest holding.
Major institutional players similarly increased their exposure. Vanguard expanded its Apple stake by 1.1% in Q2, while State Street boosted its position by 0.9%. Geode Capital Management raised its holdings by 1.4%. Norges Bank established a fresh position in Q2 valued at roughly $38.9 billion. Institutional ownership accounts for 67.73% of Apple’s total shares outstanding.
Broader Analyst Sentiment Remains Constructive
The wider analyst community maintains a generally favorable outlook, though opinions vary. JPMorgan elevated its price objective from $315 to $325 with an Overweight rating. Scotiabank established a $330 target. Goldman Sachs and Sanford C. Bernstein both maintain Buy or Outperform recommendations.
MarketBeat’s compiled data indicates a mean price target of $297.58 with a “Moderate Buy” consensus — comprising 22 Buy ratings, 12 Hold ratings, and one Sell rating. TipRanks data establishes the average at $306.12 based on 15 Buy recommendations, 9 Hold ratings, and one Sell rating.
Shares commenced Friday trading at $260.29, within a 12-month trading range of $169.21 to $288.62. The stock’s 50-day moving average rests at $263.88, marginally above its 200-day average of $260.07.
